gastroparesis and glp-1 Increased Risk Tied to GLP-1RA Use in T2DM How Dangerous Is Gastroparesis? |

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), widely used for obesity and diabetes, have recently emerged as potential therapeutic agents for IIH

Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs

These highlights do not include all the information needed to use JANUVIA safely and effectively

For example, releasing a tethered scar may improve indentation but not address excess skin, while repairing muscle separation may improve abdominal support but leave a visible lower fold if skin laxity is present

SIRT1/3-PGC-1 pathway in HD transgenic mice attenuates motor deficits and neurodegeneration by alleviating oxidative stress, eliminating huntingtin aggregates and restoring mitochondrial function